IC
RCKT icon

Ikarian Capital’s Rocket Pharmaceuticals RCKT Stock Holding History

Ikarian Capital’s Portfolio RCKT Stock Details RCKT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-221,911
Closed -$1.48M – 199
2025
Q1 		$1.48M Hold
221,911
– – 0.48% 82
2024
Q4 		$2.79M Buy
221,911
+24,815
+13% +$374K 0.8% 67
2024
Q3 		$3.64M Hold
197,096
– – 1.13% 57
2024
Q2 		$4.24M Sell
197,096
-100,000
-34% -$2.3M 1.32% 33
2024
Q1 		$8M Buy
297,096
+57,370
+24% +$1.63M 2.18% 37
2023
Q4 		$7.18M Sell
239,726
-415,000
-63% -$9.16M 1.97% 51
2023
Q3 		$13.4M Buy
+654,726
New +$11.9M 4.98% 15
2021
Q2 		– Sell
-1,400
Closed -$61K – 303
2021
Q1 		$61K Hold
1,400
– – 0.01% 282
2020
Q4 		$75K Buy
+1,400
New +$51K 0.01% 217

Other funds holding RCKT

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.6B AUM 48.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.69B AUM 86.67% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
NM
Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return